Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 3Hematologic Neoplasms 3Myelodysplastic Syndromes 2Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic-Myeloproliferative Diseases 1Mycoses 1Mucormycosis 1Glioblastoma 1Genetic Predisposition to Disease 1Candidiasis 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1Brain Neoplasms 1Aspergillosis 1

Interventions

Surveys and Questionnaires 3Interviews as Topic 2Blood Specimen Collection 2posaconazole 1Specimen Handling 1Sequence Analysis, RNA 1Prophylactic Mastectomy 1Phlebotomy 1Minoxidil 1Magnetic Resonance Spectroscopy 1Fluconazole 1Demography 1DNA 1Cephalexin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genetic Predisposition to Disease × posaconazole × 1 year × Clear all
NCT03828773 2025-12-09

PTX3AML

Centre Hospitalier Universitaire Vaudois

Phase NA Recruiting
410 enrolled
Other hematologic neoplasm

Aspergillosis, Candidiasis, Mycoses, Leukemia, Myeloid, Acute, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡